Cargando…
Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis
Pioglitazone has been reported to increase the risk of bladder cancer but the conclusions of published clinical studies are confusing. We conducted a systematic review and meta-analysis of all eligible randomized controlled trial (RCT) studies and observational studies, in order to identify a more p...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021001/ https://www.ncbi.nlm.nih.gov/pubmed/29970962 http://dx.doi.org/10.2147/CMAR.S164840 |